Skip to main content

Bacillus anthracis protective antigen Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NB120-13808PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NB120-13808PEP

Key Product Details

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

Application Notes

This peptide is useful as a blocking peptide for NB120-13808. For further blocking peptide related protocol, click here.

Specificity

This peptide is specific for NB120-13808 only.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NB120-13808PEP
Formulation Peptide dissolved in dH20. Contains no BSA.
Preservative No Preservative
Concentration 1 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -80C. Avoid freeze-thaw cycles.

Background: Bacillus anthracis protective antigen

Anthrax toxins are composed of three distinct proteins, a protective antigen (PA), a lethal factor (LF) and an edema factor (EF). None of these proteins are toxic by themselves and several studies indicate that the anthrax toxin has the familiar A-B enzymatic binding structure, with PA acting as the binding domain and EF and/or LF acting as the active fragments.

Alternate Names

anthrax PA, Anthrax toxins translocating protein, PA, PA 83, PA83, PAG, Paga, Protective antigen

Additional Bacillus anthracis protective antigen Products

Product Documents for Bacillus anthracis protective antigen Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Bacillus anthracis protective antigen Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...